Published in Front Mol Neurosci on February 28, 2017
The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res (2012) 15.41
Long noncoding RNA as modular scaffold of histone modification complexes. Science (2010) 15.23
Long noncoding RNAs: cellular address codes in development and disease. Cell (2013) 6.01
Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet (2013) 5.48
Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal (2010) 4.77
Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol (2013) 4.57
The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol (2005) 3.15
Xist RNA is a potent suppressor of hematologic cancer in mice. Cell (2013) 2.93
Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell (2014) 2.83
The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol (2014) 2.63
Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule. Cell (2014) 2.62
The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res (2011) 2.52
The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res (2006) 2.50
P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis (2014) 2.09
The emerging role of lncRNAs in cancer. Nat Med (2015) 2.06
H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem (2005) 2.04
High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation. Nature (2013) 2.00
Cancer stem cells in glioblastoma. Genes Dev (2015) 1.91
An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem (2009) 1.90
Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet (2015) 1.81
Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis (2012) 1.70
Long Noncoding RNAs in Cancer Pathways. Cancer Cell (2016) 1.63
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. Cancer Cell (2016) 1.63
Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat Commun (2013) 1.62
Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ (2013) 1.60
Long non-coding RNAs as a source of new peptides. Elife (2014) 1.56
MGMT testing--the challenges for biomarker-based glioma treatment. Nat Rev Neurol (2014) 1.54
Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One (2014) 1.52
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. Clin Cancer Res (2013) 1.51
A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog (2013) 1.51
HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro Oncol (2013) 1.47
CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment. Front Genet (2012) 1.45
A long non-coding RNA signature in glioblastoma multiforme predicts survival. Neurobiol Dis (2013) 1.42
LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol (2012) 1.40
Common Genetic Variants Influence Whorls in Fingerprint Patterns. J Invest Dermatol (2015) 1.39
ATRX directs binding of PRC2 to Xist RNA and Polycomb targets. Cell (2014) 1.38
HOTAIR: a cancer-related long non-coding RNA. Neoplasma (2014) 1.37
Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli. Nature (2014) 1.33
Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner. Oncotarget (2015) 1.29
Long noncoding RNA HOTAIR involvement in cancer. Tumour Biol (2014) 1.28
Targeting CDK4 and CDK6: From Discovery to Therapy. Cancer Discov (2015) 1.27
Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Cancer Lett (2015) 1.26
The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression. Mol Cancer (2015) 1.24
Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal (2014) 1.24
Paraspeckle formation during the biogenesis of long non-coding RNAs. RNA Biol (2013) 1.22
Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma. Nat Rev Cancer (2015) 1.15
LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat Cell Biol (2016) 1.15
Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett (2012) 1.14
Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol (2014) 1.13
CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett (2015) 1.13
Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma. Int J Clin Exp Pathol (2015) 1.07
Long noncoding RNAs in cancer: from function to translation. Trends Cancer (2015) 1.06
EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter. Stem Cells Transl Med (2012) 1.05
The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation. Proc Natl Acad Sci U S A (2015) 1.05
Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci (2016) 1.04
Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA. Genes (Basel) (2015) 1.04
A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells. Tumour Biol (2014) 1.02
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat Genet (2016) 1.02
Long noncoding RNA profiles reveal three molecular subtypes in glioma. CNS Neurosci Ther (2014) 1.00
BET bromodomain proteins are required for glioblastoma cell proliferation. Epigenetics (2014) 0.99
Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. FEBS Lett (2015) 0.99
Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Int J Clin Exp Pathol (2015) 0.98
Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326. Oncotarget (2015) 0.98
Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis. Tumour Biol (2015) 0.97
CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. Oncotarget (2015) 0.97
Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222. Mol Ther (2015) 0.97
Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. J Neurosurg (2015) 0.96
Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide. Drug Discov Today (2015) 0.95
Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells. J Neurooncol (2015) 0.95
The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget (2015) 0.95
Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis. Int J Clin Exp Med (2015) 0.95
Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling. Cell Death Dis (2016) 0.94
LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastoma multiforme. J Cancer Res Clin Oncol (2014) 0.94
Targeting autophagy to sensitive glioma to temozolomide treatment. J Exp Clin Cancer Res (2016) 0.93
Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients. APMIS (2015) 0.92
LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis. Exp Biol Med (Maywood) (2016) 0.92
HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas. Oncotarget (2016) 0.92
The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations. EMBO Mol Med (2016) 0.91
deepBase v2.0: identification, expression, evolution and function of small RNAs, LncRNAs and circular RNAs from deep-sequencing data. Nucleic Acids Res (2015) 0.91
Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis. Dis Markers (2015) 0.90
CASC2a gene is down-regulated in endometrial cancer. Anticancer Res (2007) 0.90
Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer. Tumour Biol (2016) 0.89
Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Int J Clin Exp Pathol (2015) 0.89
Knockdown of long non-coding RNA MALAT1 increases the blood-tumor barrier permeability by up-regulating miR-140. Biochim Biophys Acta (2015) 0.87
CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis. Mol Ther (2016) 0.87
Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis. Cancers (Basel) (2015) 0.87
Unique biology of gliomas: challenges and opportunities. Trends Neurosci (2012) 0.87
Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2011) 0.87
Tamoxifen-Induced Cell Death of Malignant Glioma Cells Is Brought About by Oxidative-Stress-Mediated Alterations in the Expression of BCL2 Family Members and Is Enhanced on miR-21 Inhibition. J Mol Neurosci (2015) 0.87
Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Int J Clin Exp Pathol (2015) 0.87
Identification of Stably Expressed lncRNAs as Valid Endogenous Controls for Profiling of Human Glioma. J Cancer (2015) 0.86
Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives. Oncotarget (2016) 0.86
Extracellular vesicles shed by glioma cells: pathogenic role and clinical value. Tumour Biol (2014) 0.86
Identification and functional analyses of 11,769 full-length human cDNAs focused on alternative splicing. DNA Res (2009) 0.86
Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. Hum Mutat (2004) 0.86
HOTAIR is a therapeutic target in glioblastoma. Oncotarget (2015) 0.86
Long non-coding RNAs as novel therapeutic targets in cancer. Pharmacol Res (2016) 0.86
Competing endogenous RNA networks and gastric cancer. World J Gastroenterol (2015) 0.85
LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2. J Cell Physiol (2015) 0.85
Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas. Oncotarget (2016) 0.85
The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties. Front Pharmacol (2016) 0.75